NAHLA ALABBAS, PHARM D
Pharmacist in WALNUT CREEK, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: NAHLA ALABBAS, PHARM D filed 287 Medicare Part D claims in 2023 across WALNUT CREEK, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
NAHLA ALABBAS, PHARM D at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Pharmacist compares to other specialties among California providers
Pharmacist share within California
Pharmacist is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Pharmacist ABMS/AOA estimate
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Pharmacist US NPIs
Specialty board-certified rate — Pharmacist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
NAHLA ALABBAS, PHARM D is a Pharmacist provider practicing in WALNUT CREEK, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARM D. NPI: 1740645977. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
NAHLA ALABBAS, PHARM D appears in the CMS NPPES registry as a Pharmacist provider holding PHARM D credentials at 3101 BOWLING GREEN DR, WALNUT CREEK, CA, 94598, with a listed phone of (925) 323-8587. NPI 1740645977 was issued on 12/14/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALABBAS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 287 prescription claims written by this provider, covering 232 Medicare beneficiaries and totaling roughly $81K in drug spend, split 100% brand-name and 0% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1740645977 |
|---|---|
| Specialty | Pharmacist |
| Credentials | PHARM D |
| Gender | Female |
| NPI Issued | 12/14/2015 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm NAHLA ALABBAS, PHARM D's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to NAHLA ALABBAS, PHARM D. To verify NAHLA ALABBAS, PHARM D's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
100% brand-name claims vs 0% generic, on 287 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 287
- Total Day Supply
- 287
- Brand vs Generic
- 100% brand / 0% generic
- Brand Drug Cost
- $81K
- Generic Drug Cost
- $0
Patient Demographics
- Average Patient Age
- 79.7 years
- Avg HCC Risk Score
- 1.07
- Gender Split
- 69% female / 31% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Arexvy Rsvpref3 Antigen/As01e/Pf | 205 |
| Shingrix Varicella-Zoster Ge/As01b/Pf | 55 |
| Boostrix Tdap "Diphth | N/A |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pharmacist Overview
How NAHLA ALABBAS, PHARM D fits within the Pharmacist landscape nationally.
NAHLA ALABBAS, PHARM D's 287 claims are above the specialty average of 135.
Nearby Pharmacist Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ALABBAS.
Compare Pharmacist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is NAHLA ALABBAS, PHARM D's specialty? ▼
How much does NAHLA ALABBAS, PHARM D prescribe under Medicare Part D? ▼
Where is NAHLA ALABBAS, PHARM D located? ▼
What is NAHLA ALABBAS, PHARM D's NPI number? ▼
Does NAHLA ALABBAS, PHARM D prescribe more brand-name or generic drugs? ▼
How many Pharmacist providers are there in the US? ▼
What drugs does NAHLA ALABBAS, PHARM D prescribe most often? ▼
Does NAHLA ALABBAS, PHARM D accept Medicare? ▼
How can I verify NAHLA ALABBAS, PHARM D's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology